Managing Type 2 Diabetes in Frailty within Primary Care

Size: px
Start display at page:

Download "Managing Type 2 Diabetes in Frailty within Primary Care"

Transcription

1 Managing Type 2 Diabetes in Frailty within Primary Care Author Medicines Management Pharmacist Version 1.0 Written: May 2017 Next review: May 2018 Approved by IESCCG Workstream Date approved 27/6/17 Contents Background Key points Assessment of Frailty Method Table 1: Suggested Changes in Approach to Treatment Appendix 1: Rockwood Frailty Scale Appendix 2: How to search for frail patients Appendix 3: Report Background There is increasing evidence of the relative risks and benefits of treatment of diabetes in the elderly and frail. This evidence is not reflected strongly in NICE guidance (NG28) or in the QOF targets. Elderly and frail individuals with diabetes are at marked increase in risk of adverse effects of treatments for diabetes, including admissions to hospital, and are less likely to benefit from the longterm protective effects of good glycaemia control. The number of people with diabetes in the older age groups is increasing markedly, particularly in Suffolk. There is a need for local guidance to change the way people think about diabetes management in the frail elderly, to allow a balance between the drive for tight glycaemia and blood pressure control and prevention of harm. This guideline is based on a document produced by South Devon Healthcare NHS Foundation Trust. The recommendations are based on recent published research data and consensus statements published in 2012 from the American Diabetes Association and American Geriatrics Society (Kirkman MS et al, JAGS 60:2342; 2356) and the European Diabetes Working Party for Older People (Sinclair A et al, JAMDA 13: ). Key Points Patients with life-expectancy less than 10 years may be unlikely to derive microvascular benefits from tight glycaemic control (probably 10 years if free of complications at baseline) or tight BP control. The aims of treatment for patients who are severely frail (e.g. those living in care homes or who have similar level of dependency living at home) should be (Kirkman et al): 1. To avoid hypoglycaemia 2. To control symptoms and avoid metabolic complications Page 1 of 24

2 3. To avoid unnecessary hospital admission 4. To maintain/improve quality of life 5. To introduce timely end-of-life care An unscheduled admission to hospital in an elderly or frail patient may be a marker of increased risk of recurrent hypoglycaemia and of substantial reduction in life-expectancy. De-escalation of treatment may be appropriate. All changes in medication and treatment targets will need to be discussed/ negotiated with the patient and/or carers/relatives. The reasons for suggested changes need to be understood in terms of increased risk of therapy or low likelihood of benefit. Patients can be exception reported from QOF if they are on maximal tolerated treatment or due to frailty and this is documented in the notes. Assessment of Frailty There is a variety of Frailty scales but none is widely used or validated in diabetes. The scale currently utilised in IESCCG is the efi (electronic frailty index) within SystmOne and EmisWEB which incorporates the Rockwood Scale (Appendix 1). Method For the purposes of this review, each GP Practice will be asked to identify and review two patients per thousand registered population, who may fit within the category of severely frail described in Table 1. A search should be performed to identify all patients over the age of 65 years with a frailty score of more than 0.36 using efi (see appendix 2) and type 2 diabetes. If sufficient numbers cannot be found, patients of moderate frailty (i.e. an efi of ) maybe reviewed. Please note there is no set guidance on how patients with moderate fraility should be managed and the GP will need to review the medication based on individual patient factors. Your nominated CCG practice support pharmacist and/or technician can support you with the searches. The medication review must be done by a GP. Following the review, a report must be completed by the reviewing GP (Appendix 3) The practice can then submit the information highlighting any actions or learning resulting from the review. This form should be submitted to the CCG Prescribing Team by 1st May 2018 Page 2 of 24

3 Table 1: Managing Type 2 Diabetes in Frailty: Suggested Changes in Approach to Treatment Level of Frailty Therapeutic targets Suggested actions and therapeutic options Severely Frail Symptom control De-escalate treatment Reduce drugs Avoidance of hypoglycaemia 1. Consider whether possible to stop sulphonyureas (efi score > 0.36) (no target HbA1c necessary except as a means of assessing risk of hypo glycaemia or severe metabolic decompensation) 2. Consider stopping metformin (and caution with other drugs ) if egfr is deteriorating, or below 35 or adversely impacting on appetite. 3. Do not use other third line agents ( GLP-1, Pioglitazone, SGLT-2blockers ) Avoid low levels of HbA1c <59(7.5%) if on insulin or sulphonyureas 4. Stop lipid lowering drugs 5. Stop /Reduce other drugs likely to cause adverse effects, especially Beta-blockers No need to measure alb/creat ratio Please note this serves as a guide and prescribers should make decisions based on individual patient factors. Patients should be monitored as normal following any medication changes. Please seek advice from diabetes team if patients are at danger of decompensation or are stable on drugs despite them being used outside of recommended guidelines e.g. patients stable on metformin with an efgr of <30ml/min Page 3 of 24

4 Appendix 1: Rockwood Frailty Scale

5 Appendix 2: How to search for severely frail patients using efi on SystmOne and EMISWeb SystmOne 1) Go to the reporting Tab within SystmOne and click on Miscellaneous Reports and then the Electronic Frailty Index Report. A Run Report screen will appear. 2) Go to Show top column and type 10% in the percentage of practice population you wish to search. This will ensure all relevant patients are identified. Next click Run report. This will generate efi scores for patients within a GP Practice. Page 5 of 24

6 3) The efi scores listed correlate to frailty categories. These range from Fit to Severe Frailty. - Fit: efi score = Mild frailty: efi score = Moderate frailty: efi score = Severe frailty: efi score = > ) You can export the patient data to an Excel spread sheet by right clicking the mouse and selecting Create Table, then CSV. An excel spread sheet will open you are then able to sort the table according to ascending age or efi score etc. This will be needed once the final report has been generated. 5) Within SystmOne, highlight those patients with efi of >0.36, click on Add to patient group icon and call it efi>0.36. Please note only 150 patients can be added to a single group. Multiple groups may need to be created depending on the number of patients identified in the efi report. In such cases it should be named according the range of efi scores for patients contains within that group e.g. efi ) Run a report to identify those patients that are more than 65+yrs, have type 2 diabetes and are severely frail by clicking on the reporting tab and selecting Clinical reporting 7) Click on new report and name it Diabetes Type 2 and efi>0.36 or Diabetes Type 2 and efi between and. if multiple groups were created at step 5. The name used to create the group should be reflected in the title of the report. Page 6 of 24

7 8) Click on Registration on the drop down menus to the left then select Caseload/Team 9) Select the third option that appears, Restrict to patient group, click on Select group and pick the group which was created in step 5. If multiple groups were created, select the group with the frailest patients. Page 7 of 24

8 10) Click on Clinical on the drop down menus to the left then select Read coded entries 11) Select the second option Read codes and click on Select read codes Page 8 of 24

9 12) On the new pop up click the red R icon under Codes and their children to match on Page 9 of 24

10 13) Type in /dm2 and click ok Page 10 of 24

11 14) On the left side click on the Demographic drop down option and click on Age. In the box tick Current age and configure the options to search patients over 65 yrs and click ok and the report will appear. Page 11 of 24

12 15) Run the report and it will identify the number of patients who are >65yrs old with Type 2 diabetes and are severely frail (depending on the group that was added at step 9). 16) Use the excel file created at step 4 to identify the frailest patients generated as the report cannot specify the frailty score. These patients should be prioritised when undertaking the reviews. If multiple groups were created at step 5 a separate report would need to be made up for each group. This should be done if sufficient numbers cannot be identified after running the first report. Useful information If you wish to find the groups that were created in step 5, navigate to the reporting tab, click on Miscellaneous Reporting and click on Ad Hoc Patient List Page 12 of 24

13 Select on group and double click to show all patients within that group You can export the table to an Excel spread sheet by right clicking the mouse and selecting Create Table, then CSV. An excel spread sheet will open you are then able to sort the table according to age, efi score etc. EmisWEB Currently there is no function to search the practice list like the method used for SystmONE. Patients can only have a score added on if there is a prompt in the QOF alert box in the bottom right corner after entering each individual patient record. Once the patient has been scored, it will be added onto the record. A search can be set up to identify those patients and the other criteria i.e. over 65 and type 2 diabetes can be added onto the search. Practices are encouraged to add the efi score when prompted to do so to allow them the best possible chance if finding patients for the purpose of this scheme. The information below will explain how to set up the search. However if practices are not able to find any patients then they should look at patients in care homes that are aligned to the practice as these will be the most frail. Their records should be accessed to see if the frailty prompt appears within the QOF box and score the patient as needed. Page 13 of 24

14 1) Within the main EMIS home screen click on population reporting 2) Right click on the folder you wish you save the search in and select Add then Search Page 14 of 24

15 3) Choose a title and ensure the option for Currently registered regular patients is selected 4) Click on the option and select Create a new rule Page 15 of 24

16 5) Click on add criteria then select Clinical code and then New code list Page 16 of 24

17 6) In the search box type in frailty and then select FI-Fraility Index so it appears in the selected codes section and click OK Page 17 of 24

18 7) On the search screen click on Add another rule and select clinical codes Page 18 of 24

19 8) Type in diabetes and the select Type 2 diabetes mellitus on the right side under code hierarchy. All read codes associated with Type 2 diabetes will appear below under selected codes and click OK Page 19 of 24

20 9) Click on add another rule and select Patients then Patient details. In the Age criteria box ensure it states older than 65 years and click OK. The search is now ready to be used. Page 20 of 24

21 Appendix 3 Report Practice Name Date report submitted to the CCG Total number of patients identified and reviewed List size on 1/1/17 Total number of patients where the management was changed based on the recommendations Patient review 1 Date of review Review undertaken by (inc name and job title) efi score of patient Changes made/comments

22 How will you follow up this work? Page 22 of 24

23 Page 23 of 24

24 Page 24 of 24

Frailty and Type 2 Diabetes Guidelines for clinicians

Frailty and Type 2 Diabetes Guidelines for clinicians H.G. WELLS PROJECT Frailty and Type 2 Diabetes Guidelines for clinicians Victoria Ruszala victoria.ruszala@nhs.net H.G. Wells Project team Dugal T, Partington E. Kernow CCG Diabetes and Frailty Guideline

More information

ProScript User Guide. Pharmacy Access Medicines Manager

ProScript User Guide. Pharmacy Access Medicines Manager User Guide Pharmacy Access Medicines Manager Version 3.0.0 Release Date 01/03/2014 Last Reviewed 11/04/2014 Author Rx Systems Service Desk (T): 01923 474 600 Service Desk (E): servicedesk@rxsystems.co.uk

More information

Medtech Training Guide

Medtech Training Guide Medtech Training Guide Clinical Audit Tool Copyright Medtech Limited Page 1 of 80 Clinical Audit Tool v4.0 Contents Chapter 1: Getting Started... 3 Logging In... 3 Logging Out... 3 Setting the Preliminary

More information

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators NICE Indicator Programme Consultation on proposed amendments to current QOF s Consultation dates: 18 July to 1 August 2018 This document outlines proposed amendments to a small number of QOF s in the diabetes

More information

HEART FAILURE TOOL. Instructions and Guide. Version: Jan-2016

HEART FAILURE TOOL. Instructions and Guide. Version: Jan-2016 HEART FAILURE TOOL Instructions and Guide Version: 1.1 4-Jan-2016 Clinical Effectiveness Group Centre for Primary Care & Public Health Blizard Institute Queen Mary University of London London, England

More information

FGM Data Collection NHS Digital CAP

FGM Data Collection NHS Digital CAP FGM Data Collection - NHS Digital Document name: FGM Data Collection NHS Digital CAP Project / Programme: FGM Enhanced Data set NHS Digital / Data upload Project Managers: NWLCCGS: Sonia Spiteri Sharon

More information

BlueBayCT - Warfarin User Guide

BlueBayCT - Warfarin User Guide BlueBayCT - Warfarin User Guide December 2012 Help Desk 0845 5211241 Contents Getting Started... 1 Before you start... 1 About this guide... 1 Conventions... 1 Notes... 1 Warfarin Management... 2 New INR/Warfarin

More information

Anticoagulation Manager - Getting Started

Anticoagulation Manager - Getting Started Vision 3 Anticoagulation Manager - Getting Started Copyright INPS Ltd 2014 The Bread Factory, 1A Broughton Street, Battersea, London, SW8 3QJ T: +44 (0) 207 501700 F:+44 (0) 207 5017100 W: www.inps.co.uk

More information

Ref. Version Supersedes Approved for Date approved Document Owner N/A MMT 17/01/2017 Lois Taylor. Switching to Alogliptin (Vipidia )

Ref. Version Supersedes Approved for Date approved Document Owner N/A MMT 17/01/2017 Lois Taylor. Switching to Alogliptin (Vipidia ) Ref. Version Supersedes Approved for Date approved Document number use by Owner 001 1.0 N/A MMT 17/01/2017 Lois Taylor Aim: Switching to Alogliptin (Vipidia ) To reduce our spend on gliptins (DDP-4 drugs)

More information

Warfarin Help Documentation

Warfarin Help Documentation Warfarin Help Documentation Table Of Contents Warfarin Management... 1 iii Warfarin Management Warfarin Management The Warfarin Management module is a powerful tool for monitoring INR results and advising

More information

Patient Safety Queries DMARDs, Warfarin and Triple Whammy. Version th July User Guide for GP Practices SPIRE Local (v1.2.

Patient Safety Queries DMARDs, Warfarin and Triple Whammy. Version th July User Guide for GP Practices SPIRE Local (v1.2. Patient Safety Queries DMARDs, Warfarin and Triple Whammy Version 1.0 4 th July 2017 User Guide for GP Practices SPIRE Local (v1.2.54) Contents 1 Introduction... 3 1.1 Patient Safety Queries... 3 1.2 Frequency...

More information

User Guide for Classification of Diabetes: A search tool for identifying miscoded, misclassified or misdiagnosed patients

User Guide for Classification of Diabetes: A search tool for identifying miscoded, misclassified or misdiagnosed patients User Guide for Classification of Diabetes: A search tool for identifying miscoded, misclassified or misdiagnosed patients For use with isoft Premiere Synergy Produced by André Ring 1 Table of Contents

More information

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes Version Control Version Number Date Amendments made 1 January 2018 1.1 February 2018 Amended to reflect updated SPC advice for sitagliptin

More information

SystmOne Technical Guidance

SystmOne Technical Guidance SystmOne Technical Guidance Updated February 2018 1 Dementia 18-19 Technical Solution SystmOne Implementation Guide Summary A resource to provide system support to clinicians and CCGs to: Data cleansing

More information

MANAGEMENT OF TYPE 2 DIABETES

MANAGEMENT OF TYPE 2 DIABETES MANAGEMENT OF TYPE 2 DIABETES 3 Month trial of lifestyle changes. Refer to DESMOND structured education programme. Set glycaemic target HbA1c < 7.0% (53mmol/mol) or individualised If HbA1c > 53mmol/mol

More information

Dementia Direct Enhanced Service

Dementia Direct Enhanced Service Vision 3 Dementia Direct Enhanced Service England Outcomes Manager Copyright INPS Ltd 2015 The Bread Factory, 1A Broughton Street, Battersea, London, SW8 3QJ T: +44 (0) 207 501700 F:+44 (0) 207 5017100

More information

Dementia data harmonisation: South of England Protocol

Dementia data harmonisation: South of England Protocol Dementia data harmonisation: South of England Protocol Background 1. In 2013 an aspiration was agreed between the Department of Health and the new-look NHS England that by 2015 two-thirds of people with

More information

Toward a Comprehensive Diabetes Care Model for Older People

Toward a Comprehensive Diabetes Care Model for Older People Toward a Comprehensive Diabetes Care Model for Older People Professor L. Rodriguez Mañas Hospital Universitario de Getafe Madrid, Spain Professor Alan J Sinclair Professor of Medicine and Consultant Diabetologist

More information

Integration; Frailty; and efi

Integration; Frailty; and efi Integration; Frailty; and efi John Young Geriatrician, Bradford Hospitals Trust, UK National Clinical Director for Integration & the Frail Elderly, NHS England (john.young@bthft.nhs.uk) NHS England Older

More information

Cerner COMPASS ICD-10 Transition Guide

Cerner COMPASS ICD-10 Transition Guide Cerner COMPASS ICD-10 Transition Guide Dx Assistant Purpose: To educate Seton clinicians regarding workflow changes within Cerner COMPASS subsequent to ICD-10 transition. Scope: Basic modules and functionality

More information

Data Management System (DMS) User Guide

Data Management System (DMS) User Guide Data Management System (DMS) User Guide Eversense and the Eversense logo are trademarks of Senseonics, Incorporated. Other brands and their products are trademarks or registered trademarks of their respective

More information

The Hospital Anxiety and Depression Scale Guidance and Information

The Hospital Anxiety and Depression Scale Guidance and Information The Hospital Anxiety and Depression Scale Guidance and Information About Testwise Testwise is the powerful online testing platform developed by GL Assessment to host its digital tests. Many of GL Assessment

More information

CaseBuilder - Quick Reference Guide

CaseBuilder - Quick Reference Guide ADP UNEMPLOYMENT COMPENSATION MANAGEMENT CaseBuilder - Quick Reference Guide After signing into CaseBuilder, the first screen the user will see is called the Dashboard. The user can then navigate to any

More information

Clinical Audit Tool. Release Notes

Clinical Audit Tool. Release Notes Clinical Audit Tool Version 1.0.46 (July 2013) Release Notes These Release Notes contain important information for all Medtech Users. Please ensure that they are circulated amongst all your staff. We suggest

More information

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice. Type 2 Diabetes Stopping Smoking Consider referral to smoking cessation BMI > 25 kg m² Set a weight loss target of a 5-10% reduction Consider referring for weight management advice Control BP to

More information

Diabetes Care Audit Instructional Guide

Diabetes Care Audit Instructional Guide Diabetes Care Audit Instructional Guide PRIMIS development of the Diabetes Care audit tool has been funded by Boehringer Ingelheim and Lilly Diabetes Alliance. Boehringer Ingelheim and Lilly Diabetes Alliance

More information

Cancer Decision Support Tool Walk through user guide

Cancer Decision Support Tool Walk through user guide These screenshots show exactly how a GP should use the CDS tool, covering the three ways in which it works, and how to log in to the software. Logging into the software It s really easy to log into the

More information

PedCath IMPACT User s Guide

PedCath IMPACT User s Guide PedCath IMPACT User s Guide Contents Overview... 3 IMPACT Overview... 3 PedCath IMPACT Registry Module... 3 More on Work Flow... 4 Case Complete Checkoff... 4 PedCath Cath Report/IMPACT Shared Data...

More information

POPULATION TRACKER MIDS USER GUIDE

POPULATION TRACKER MIDS USER GUIDE POPULATION TRACKER MIDS USER GUIDE December 2018 IFU-0003 14 TABLE OF CONTENTS TABLE OF CONTENTS... 1 Intended Use... 1 Warnings... 1 Contraindications... 1 Compatible Browsers... 2 Treatment Plan Templates

More information

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management

More information

GLOOKO FOR ios MIDS USER GUIDE

GLOOKO FOR ios MIDS USER GUIDE GLOOKO FOR ios MIDS USER GUIDE October 2018 IFU-0001 13 Glooko MIDS is cleared for US only Rx only TABLE OF CONTENTS TABLE OF CONTENTS MOBILE INSULIN DOSING SYSTEM (MIDS)... 2 Intended Use... 2 Warnings...

More information

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines

More information

WORKING DOCUMENT Version 5 DRAFT LOCAL ENHANCED SERVICE SPECIFICATION Palliative Care

WORKING DOCUMENT Version 5 DRAFT LOCAL ENHANCED SERVICE SPECIFICATION Palliative Care Appendix F WORKING DOCUMENT Version 5 DRAFT LOCAL ENHANCED SERVICE SPECIFICATION Palliative Care Introduction 1. The LES has been introduced to embed good clinical practice and effective performance management

More information

Coronary Heart Disease and Stroke, Primary and Secondary Prevention Guidelines (Cholesterol)

Coronary Heart Disease and Stroke, Primary and Secondary Prevention Guidelines (Cholesterol) CLINICAL GUIDELINE Coronary Heart Disease and Stroke, Primary and Secondary Prevention Guidelines (Cholesterol) A guideline is intended to assist healthcare professionals in the choice of disease-specific

More information

IT Solutions to Support Prevalence, Case Finding, Diagnosis & Care Planning in Dementia

IT Solutions to Support Prevalence, Case Finding, Diagnosis & Care Planning in Dementia IT Solutions to Support Prevalence, Case Finding, Diagnosis & Care Planning in Dementia "High Quality Care for All, Now and for Future Generations" Dementia Diagnosis - Why is it important Dr Sara Humphrey

More information

Quality Improvement Tool Instruction Guide Diabetes Care

Quality Improvement Tool Instruction Guide Diabetes Care PRIMIS: Quality Improvement Tool Instruction Guide Quality Improvement Tool Instruction Guide Diabetes Care PRIMIS development of the Diabetes Quality Improvement tool has been funded by Boehringer Ingelheim.

More information

شءءذص Primary Care Respiratory. Tools to help you stratify people with asthma who should be offered a priority review

شءءذص Primary Care Respiratory. Tools to help you stratify people with asthma who should be offered a priority review م م مء مكى مس Tools to help you stratify people with asthma who should be offered a priority review explores how to help stratify people with asthma providing م ف م خ links to XML files you can access

More information

Information Management in General Practice

Information Management in General Practice Information Management in General Practice Using PEN Clinical Audit Tool Training Workbook for General Practice Written by Noel Stewart March 2010 Workbook and Training Course for General Practice Acknowledgments:

More information

Section D. Identification of serotype-specific amino acid positions in DENV NS1. Objective

Section D. Identification of serotype-specific amino acid positions in DENV NS1. Objective Section D. Identification of serotype-specific amino acid positions in DENV NS1 Objective Upon completion of this exercise, you will be able to use the Virus Pathogen Resource (ViPR; http://www.viprbrc.org/)

More information

Data Management System (DMS) User Guide

Data Management System (DMS) User Guide Data Management System (DMS) User Guide Eversense and the Eversense logo are trademarks of Senseonics, Incorporated. Other brands and their products are trademarks or registered trademarks of their respective

More information

FREEDOM OF INFORMATION ACT 2000 Dudley CCG: Prescribing of Antibiotics Ref: RFI0861

FREEDOM OF INFORMATION ACT 2000 Dudley CCG: Prescribing of Antibiotics Ref: RFI0861 Freedom of Information Team Dudley CCG 17 November 2017 2nd Floor, Brierley Hill Health and Social Care Centre Venture Way Brierley Hill DY5 1RU FREEDOM OF INFORMATION ACT 2000 Dudley CCG: Prescribing

More information

667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY

667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY 667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY Contents Introduction... 1 Patient Education for People with Type 2 Diabetes... 2 Dietary Advice for People with Type 2 Diabetes...

More information

Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit:

Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit: Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit: To review type 2 diabetic patients prescribed dipedtidylpeptidase-4 (DPP-4) inhibitors (linagliptin (Trajenta, saxagliptin

More information

BREEAM In-Use International 2015 Client User Guide

BREEAM In-Use International 2015 Client User Guide BREEAM In-Use International 2015 Client User Guide BREEAM In-Use International 2015 - Client User Guide V1.3.1 1 Contents Contents... 2 Log In and Registration... 3 Accessing the Online Tool... 3 Registration

More information

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Aim Review and rationalise the insulin quantities based on dosage instructions for diabetic patients in order to align

More information

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use OneTouch Reveal Web Application User Manual for Healthcare Professionals Instructions for Use Contents 2 Contents Chapter 1: Introduction...4 Product Overview...4 Intended Use...4 System Requirements...

More information

Quick Reference Guide CAT4. CAT4 Cleansing View

Quick Reference Guide CAT4. CAT4 Cleansing View Quick Reference Guide CAT4 CAT4 Cleansing View - September 2015 Organisation Contacts Sydney Office Pen CS Level 1, 35 Moore St LEICHHARDT NSW 2040 Phone: + 61 (0) 2 9506 3200 Fax: +61 (0) 2 9566

More information

Appendix B. Nodulus Observer XT Instructional Guide. 1. Setting up your project p. 2. a. Observation p. 2. b. Subjects, behaviors and coding p.

Appendix B. Nodulus Observer XT Instructional Guide. 1. Setting up your project p. 2. a. Observation p. 2. b. Subjects, behaviors and coding p. 1 Appendix B Nodulus Observer XT Instructional Guide Sections: 1. Setting up your project p. 2 a. Observation p. 2 b. Subjects, behaviors and coding p. 3 c. Independent variables p. 4 2. Carry out an observation

More information

Emis Web Technical Guidance

Emis Web Technical Guidance Emis Web Technical Guidance Updated February 2018 1 Dementia 18-19 Technical Solution Emis Web Implementation Guide Summary A resource to provide system support to clinicians and CCGs to: Data cleansing

More information

How Immunisations work in Best Practice?

How Immunisations work in Best Practice? How Immunisations work in Best Practice? There are a number of areas in Best Practice related to Immunisations:- Recording and updating Immunisation records Searching and Printing Immunisations List Printing

More information

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4 GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services

More information

2. Evidence of continued professional development in this area on a 2 yearly basis

2. Evidence of continued professional development in this area on a 2 yearly basis Nutrition and Physical Activity Diabetes Competencies briefing document from the Diabetes Education and management Group (DMEG) and Diabetes UK - May 2013 The Quality and Outcomes Framework (QOF) requirement

More information

Digital strategy for the NENE ICS Enabling the transformation of care through the use of digital technology

Digital strategy for the NENE ICS Enabling the transformation of care through the use of digital technology Digital strategy for the NENE ICS Enabling the transformation of care through the use of digital technology Dr Mark Dornan Digital Care Programme SRO North East and North Cumbria STP/ICS Programmes Optimising

More information

Changing care systems for people with frailty. John Young

Changing care systems for people with frailty. John Young Changing care systems for people with frailty John Young Geriatrician, Bradford Hospitals Trust, UK National Clinical Director for Integration & the Frail Elderly, NHS England (john.young@bthft.nhs.uk)

More information

A Suite of Enhanced Services for. Prudent Structured Care for Adults with Type 2 Diabetes

A Suite of Enhanced Services for. Prudent Structured Care for Adults with Type 2 Diabetes An Enhanced Service for Prudent Structured Care for Adults with Type 2 Diabetes Page 1 A Suite of Enhanced Services for Prudent Structured Care for Adults with Type 2 Diabetes 1. Introduction All practices

More information

Referral to Adult Diabetes Specialist Services

Referral to Adult Diabetes Specialist Services Referral to Adult Diabetes Services Aim(s) and objective(s) To ensure that those people with Diabetes Mellitus (DM) who live within Lanarkshire are appropriately referred to the Diabetes Service (Consultant,

More information

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by (Vale of York CCG/date)

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by (Vale of York CCG/date) Drug, Treatment, Device name ( Vipidia; Takeda) COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by (Vale of York CCG/date) Licensed indication To improve glycaemic control in

More information

Hypertension targets in the elderly. Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016

Hypertension targets in the elderly. Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016 Hypertension targets in the elderly Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016 NICE (2011) Aim for a target clinic blood pressure below 150/90 mmhg in people aged 80

More information

CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care

CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care Technical guidance NHS England INFORMATION READER BOX Directorate

More information

Tier 3 and 4 healthy weight and obesity services in Kent

Tier 3 and 4 healthy weight and obesity services in Kent Tier 3 and 4 healthy weight and obesity services in Kent Model user guide September 2016 1 Background Tier 3 healthy weight services for Kent residents are currently commissioned by Kent County Council

More information

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57) Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus

More information

Heart Failure Management in Primary Care

Heart Failure Management in Primary Care Heart Failure Management in Primary Care Going Beyond QOF and implementing NICE Guidance through Enhance HF Kavita Oberoi OBE Founder & Managing Director Oberoi Consulting This session is fully funded

More information

Data Management System (DMS) User Guide

Data Management System (DMS) User Guide Data Management System (DMS) User Guide Eversense and the Eversense logo are trademarks of Senseonics, Incorporated. Other brands and their products are trademarks or registered trademarks of their respective

More information

EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens

EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens This document should be read in conjunction with the current Summary of Product Characteristics http://www.medicines.org.uk 1.

More information

RenalSmart (diabetic) Instruction Manual

RenalSmart (diabetic) Instruction Manual RenalSmart (diabetic) Instruction Manual Stepwise Approach Access to Application Patient details Dietary management: Food Options Dietary mangement: Consultation Dietary mangement: Previous consultation

More information

Data Management, Data Management PLUS User Guide

Data Management, Data Management PLUS User Guide Data Management, Data Management PLUS User Guide Table of Contents Introduction 3 SHOEBOX Data Management and Data Management PLUS (DM+) for Individual Users 4 Portal Login 4 Working With Your Data 5 Manually

More information

ATLANTIS WebOrder. ATLANTIS ISUS User guide

ATLANTIS WebOrder. ATLANTIS ISUS User guide ATLANTIS WebOrder ATLANTIS ISUS User guide Contents ATLANTIS WebOrder Entering an ATLANTIS ISUS order 3 ATLANTIS ISUS implant suprastructures 4 ATLANTIS ISUS Bar 5 ATLANTIS ISUS Bridge 7 ATLANTIS ISUS

More information

MedsCheck Reviews. Ontario

MedsCheck Reviews. Ontario MedsCheck Reviews Ontario Contents Configuration... 1 Configuring Electronic Signatures... 1 Configuring Electronic MedsCheck Reviews... 2 Creating an ODB MedsCheck Consent Record... 3 Electronic MedsCheck

More information

Clay Tablet Connector for hybris. User Guide. Version 1.5.0

Clay Tablet Connector for hybris. User Guide. Version 1.5.0 Clay Tablet Connector for hybris User Guide Version 1.5.0 August 4, 2016 Copyright Copyright 2005-2016 Clay Tablet Technologies Inc. All rights reserved. All rights reserved. This document and its content

More information

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG Shaping Diabetes Services in Southern Derbyshire A vision for Diabetes Services For Southern Derbyshire CCG Vanessa Vale Commissioning Manager September 2013 Contents 1. Introduction 3 2. National Guidance

More information

Vaccination Setup. Immunization Set Up & Reporting

Vaccination Setup. Immunization Set Up & Reporting Vaccination Setup Immunization Set Up & Reporting To set up vaccination codes, waivers, links, combination vaccines, etc. The pathway is Office VaccinationsSetupCodes. See Cloning Vaccination Rules Code

More information

Practice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting

Practice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting Practice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting Name of Practice Contact details of practice staff who you would like a copy of this questionnaire to be sent to when

More information

Your pathway to success

Your pathway to success Your pathway to success Why Map of Medicine? Because we ll support you every step of the way... Map of Medicine has provided invaluable hand holding and advice with the shaping and publication of local

More information

Cleansing CAT Module Quick Reference Guide Version 3.12

Cleansing CAT Module Quick Reference Guide Version 3.12 Getting Started Installation Refer to the PCS Clinical Audit Tool Quick Reference Guide for installation instructions and an overview of CAT features. Cleansing CAT Overview The Cleansing CAT module allows

More information

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine Ref No: E053 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine NOTE: Please complete details on P1 &3 Send one copy to GP, Patient and file

More information

National Institute for Health and Care Excellence. Type 2 diabetes. Stakeholder Comments Draft Guideline

National Institute for Health and Care Excellence. Type 2 diabetes. Stakeholder Comments Draft Guideline National Institute for Health and Care Excellence Type 2 diabetes Stakeholder Comments Draft Guideline NOTE: NICE is unable to accept comments from non-registered organisations or individuals. If you wish

More information

Optimising Insulin Pen Needles

Optimising Insulin Pen Needles Optimising Insulin Pen Needles Following a review of insulin pen needles NHS Telford and Wrekin CCG now recommends the use of GlucoRx FinePoint Pen Needles. GlucoRx FinePoint Pen Needles are a high quality

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

cigarettedesigner 4.0

cigarettedesigner 4.0 cigarettedesigner 4.0 Manual Installing the Software To install the software double-click on cigarettedesignerzip.exe to extract the compressed files and then double click on Setup.msi to start the installation

More information

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes

More information

Living well with frailty. JOHN YOUNG National Clinical Director for the Frail Elderly & Integration, NHS England

Living well with frailty. JOHN YOUNG National Clinical Director for the Frail Elderly & Integration, NHS England Living well with frailty JOHN YOUNG National Clinical Director for the Frail Elderly & Integration, NHS England A LTC rarely travels alone Kent Whole Population Dataset: Interim Report 2014 The burden

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Single Technology Appraisal Canagliflozin in combination therapy for Final scope Remit/appraisal objective To appraise the clinical and cost effectiveness

More information

Essential Shared Care Agreement: Lithium

Essential Shared Care Agreement: Lithium Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed

More information

In Class Problem Discovery of Drug Side Effect Using Study Designer

In Class Problem Discovery of Drug Side Effect Using Study Designer In Class Problem Discovery of Drug Side Effect Using Study Designer November 12, 2015 Version 30 Tutorial 25: In Class problem Discovery of drug side effect Gatifloxacin. https://www.youtube.com/watch?v=2die3bc3dzg

More information

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service

More information

Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options?

Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options? Patient decision aid Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options? nice.org.uk/guidance/ng28 Published: December 2015 About this decision

More information

Diabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust

Diabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust Diabetes Update: Keeping patients safe Victoria Ruszala MFRPSII North Bristol NHS Trust Declaration of Interests I have received funding from the following companies for providing education sessions, attending

More information

Content Part 2 Users manual... 4

Content Part 2 Users manual... 4 Content Part 2 Users manual... 4 Introduction. What is Kleos... 4 Case management... 5 Identity management... 9 Document management... 11 Document generation... 15 e-mail management... 15 Installation

More information

User Instruction Guide

User Instruction Guide User Instruction Guide Table of Contents Logging In and Logging Out of MMSx 1 Creating a TPN (Terminal Profile Number) 2 Single Merchant 2 From Navigation Bar 2 From Home Page Link 4 Multiple Merchants

More information

Wolf Panel Clean-up. Initial Panel Clean-up Dashboard Active Pts. Set up Coded Problems in Problem List (Profile) Clean-up Patient Demographics

Wolf Panel Clean-up. Initial Panel Clean-up Dashboard Active Pts. Set up Coded Problems in Problem List (Profile) Clean-up Patient Demographics Wolf Panel Clean-up Initial Panel Clean-up Dashboard Active Pts. Set up Coded Problems in Problem List (Profile) Clean-up Patient Demographics Case Finding by Name or ICD9 Code in Problem List Using Billing

More information

BRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI

BRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI CASE AUTH/2638/9/13 and AUTH/2639/9/13 BRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI Promotion of Lyxumia Bristol-Myers Squibb and AstraZeneca jointly complained about cost comparison claims in a Lyxumia

More information

2. Quality and Outcomes Framework: new NICE recommendations

2. Quality and Outcomes Framework: new NICE recommendations Proposed Changes to the GMS Contract 2013/14 1. GP pay and expenses uplift It is proposed GP pay and expenses is uplifted by 1.5%. This increased investment will allow for an average pay increase of up

More information

Agile Product Lifecycle Management for Process

Agile Product Lifecycle Management for Process Nutrition Surveillance Management User Guide Release 5.2.1 Part No. E13901-01 September 2008 Copyrights and Trademarks Copyright 1995, 2008, Oracle Corporation and/or its affiliates. All rights reserved.

More information

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only)

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only) E099 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only) NOTE: Please complete details on P1 &3 Send one copy to GP, Patient and

More information

Diagnosis and management of diabetes in older people

Diagnosis and management of diabetes in older people Diagnosis and management of diabetes in older people Anne Kilvert 1 MD, FRCP, Consultant Physician Charles Fox 1 BM, FRCP, Consultant Physician 1 Northampton General Hospital, Cliftonville, Northampton,

More information

Datix Ref:

Datix Ref: Title Document Details Shared Care Agreement: Antipsychotics (Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine) Trust Ref No 2081-38933 Local Ref (optional) Main points the document

More information

Improving Data Entry of CD4 Counts. March 2012

Improving Data Entry of CD4 Counts. March 2012 Improving Data Entry of CD4 Counts March 2012 Welcome! The State Office of AIDS (OA) is continuing to work with providers to improve the quality of data that is collected and entered into ARIES. Today

More information

People living with frailty: View from NHS England. John Young

People living with frailty: View from NHS England. John Young People living with frailty: View from NHS England John Young Geriatrician, Bradford Hospitals Trust, UK National Clinical Director for Integration & the Frail Elderly, NHS England (john.young@bthft.nhs.uk)

More information

Deprescribing: A Practical Guide

Deprescribing: A Practical Guide Deprescribing: A Practical Guide The information in this booklet should be used as a pragmatic decision aid, in conjunction with other relevant patient specific data. Useful resource links http://www.derbyshiremedicinesmanagement.nhs.uk/assets/clinical_guidelines/clinical_guidelines_fr

More information

Smoking cessation interventions and services

Smoking cessation interventions and services National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These

More information